ERNA vs. VT

Last updated Aug 1, 2026

ERNA (Eterna Therapeutics Inc) is a stock, while VT (Vanguard Total World Stock ETF) is Global Equities fund tracking the FTSE Global All Cap Index. Over the past 10 years, ERNA returned -64.30%/yr vs 12.39%/yr for VT. Their 0.12 correlation means their historical movements had little consistent relationship.

Performance

ERNA vs. VT - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Eterna Therapeutics Inc (ERNA) and Vanguard Total World Stock ETF (VT). The values are adjusted to include any dividend payments, if applicable.

Returns By Period

In the year-to-date period, ERNA achieves a -89.07% return, which is significantly lower than VT's 11.15% return. Over the past 10 years, ERNA has underperformed VT with an annualized return of -64.30%, while VT has yielded a comparatively higher 12.39% annualized return.

ERNA

• 1D: -5.48%
• 1M: -47.69%
• 6M: -89.25%
• YTD: -89.07%
• 1Y: -91.59%
• 3Y*: -85.19%
• 5Y*: -86.94%
• 10Y*: -64.30%
• ALL TIME*: -33.20%

VT

• 1D: 0.26%
• 1M: -0.20%
• 6M: 7.80%
• YTD: 11.15%
• 1Y: 23.51%
• 3Y*: 18.19%
• 5Y*: 10.58%
• 10Y*: 12.39%
• ALL TIME*: 8.81%

*Multi-year figures are annualized to reflect compound growth (CAGR)

Liquidity Comparison

Position	Avg. Volume Value (2W)	Avg. Volume Value (1M)	Avg. Volume Value (3M)
ERNA Eterna Therapeutics Inc	$350.09K	$8.77M	$15.38M
VT Vanguard Total World Stock ETF	$425.08M	$369.63M	$481.55M

ERNA vs. VT - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021	2020	2019	2018	2017
ERNA Eterna Therapeutics Inc	-89.07%	-72.79%	-83.62%	-44.25%	-96.14%	-6.92%	1.82%	12.82%	-53.68%	-50.47%
VT Vanguard Total World Stock ETF	11.15%	22.43%	16.49%	22.02%	-18.00%	18.27%	16.59%	26.81%	-9.76%	24.50%

Correlation

The correlation between ERNA and VT is 0.16, which is low. Their historical price movements had little consistent relationship.

	Correlation
Correlation (1Y) Focuses on recent behavior, but can change the most.	0.16
Correlation (3Y) Balances recent behavior with more history.	0.18
Correlation (5Y) Shows whether the relationship held over a longer period.	0.27
Correlation (10Y) Provides a long-term view across more market conditions.	0.16
Correlation (All Time) Calculated using the full available price history since Jun 26, 2008	0.12

The correlation between ERNA and VT shifts across timeframes, from 0.12 (all time) to 0.27 (5 years), reflecting how their relationship changes across market environments.

Return for Risk

ERNA vs. VT — Risk / Return Rank

Compare historical risk-adjusted metric ranks over the past 12 months.

ERNA

ERNA Risk / Return Rank: 8
ERNA Sharpe Ratio Rank: 17
ERNA Sortino Ratio Rank: 6
ERNA Omega Ratio Rank: 8
ERNA Calmar Ratio Rank: 2
ERNA Martin Ratio Rank: 6

VT

VT Risk / Return Rank: 70
VT Sharpe Ratio Rank: 71
VT Sortino Ratio Rank: 69
VT Omega Ratio Rank: 69
VT Calmar Ratio Rank: 67
VT Martin Ratio Rank: 76

The rank (0–100) uses a weighted average of the Sharpe, Sortino, Omega, Calmar, and Martin percentile ranks for the trailing 12 months. Higher means stronger historical risk-adjusted performance within the peer group.

ERNA vs. VT - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Eterna Therapeutics Inc (ERNA) and Vanguard Total World Stock ETF (VT). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.

	ERNA	VT	Difference
Sharpe ratio: Return per unit of total volatility	-0.60	1.59	-2.19
Sortino ratio: Return per unit of downside risk	-1.53	2.23	-3.76
Omega ratio: Gain probability vs. loss probability	0.82	1.29	-0.47
Calmar ratio: Return relative to maximum drawdown	-0.99	2.29	-3.29
Martin ratio: Return relative to average drawdown	-1.47	9.54	-11.01

ERNA vs. VT - Sharpe Ratio Comparison

The current ERNA Sharpe Ratio is -0.60, which is lower than the VT Sharpe Ratio of 1.59. The chart below compares the historical Sharpe Ratios of ERNA and VT, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.

Drawdowns

ERNA vs. VT - Drawdown Comparison

The maximum ERNA drawdown since its inception was -100.00%, which is greater than VT's maximum drawdown of -50.27%. Use the drawdown chart below to compare losses from any high point for ERNA and VT.

Drawdown Indicators

	ERNA	VT	Difference
Max Drawdown Largest peak-to-trough decline	-100.00%	-50.27%	-49.73%
Max Drawdown (1Y) Largest decline over 1 year	-93.02%	-9.67%	-83.35%
Max Drawdown (3Y) Largest decline over 3 years	-99.70%	-16.51%	-83.19%
Max Drawdown (5Y) Largest decline over 5 years	-100.00%	-26.38%	-73.62%
Max Drawdown (10Y) Largest decline over 10 years	-100.00%	-34.24%	-65.76%
Current Drawdown Current decline from peak	-100.00%	-1.84%	-98.16%
Average Drawdown Average peak-to-trough decline	-86.20%	-6.97%	-79.23%
Ulcer Index Depth and duration of drawdowns from previous peaks	62.71%	2.32%	+60.39%

Volatility

ERNA vs. VT - Volatility Comparison

Eterna Therapeutics Inc (ERNA) has a higher volatility of 35.09% compared to Vanguard Total World Stock ETF (VT) at 3.99%. This indicates that ERNA's price experiences larger fluctuations and is considered to be riskier than VT based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	ERNA	VT	Difference
Volatility (1M) Calculated over the trailing 1-month period	35.09%	3.99%	+31.10%
Volatility (6M) Calculated over the trailing 6-month period	132.84%	11.68%	+121.16%
Volatility (1Y) Calculated over the trailing 1-year period	154.51%	13.96%	+140.55%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	114.04%	16.22%	+97.82%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	149.29%	17.18%	+132.11%

Dividends

ERNA vs. VT - Dividend Comparison

ERNA has not paid dividends to shareholders, while VT's dividend yield for the trailing twelve months is around 1.59%.

Position	TTM	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
ERNA Eterna Therapeutics Inc	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
VT Vanguard Total World Stock ETF	1.59%	1.82%	1.95%	2.08%	2.20%	1.82%	1.66%	2.32%	2.53%	2.11%	2.39%	2.45%

Frequently Asked Questions

Can I hold both ERNA and VT in my portfolio?

ERNA and VT have a correlation of 0.16, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

Which is riskier, ERNA or VT?

ERNA has higher volatility (35.09%) compared to VT (3.99%). In terms of maximum drawdown, ERNA dropped -100.00% vs VT's -50.27%.

Which has better risk-adjusted returns?

VT currently has the higher Sharpe Ratio (1.59 vs -0.60), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.